早发型帕金森病的诊断与治疗中国专家共识

2021-12-21 ANDs 网络

早发型帕金森病的诊治,看看指南怎么说?

早发型帕金森病的诊断与治疗中国专家共识

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1664142, encodeId=a6ee1664142a3, content=<a href='/topic/show?id=a20c59283e5' target=_blank style='color:#2F92EE;'>#早发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59283, encryptionId=a20c59283e5, topicName=早发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c425715601, createdName=ms7258648636991762, createdTime=Wed Jun 01 06:43:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719138, encodeId=0bf31e1913808, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Thu Nov 03 22:43:27 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741679, encodeId=48fa1e4167934, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sat Aug 13 21:43:27 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845888, encodeId=6b3a18458883e, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Mon Aug 15 19:43:27 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185608, encodeId=01fa1185608d2, content=看不清, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Tue Jan 18 13:38:59 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082995, encodeId=f5a51082995e3, content=很受益,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Wed Dec 22 10:28:55 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1664142, encodeId=a6ee1664142a3, content=<a href='/topic/show?id=a20c59283e5' target=_blank style='color:#2F92EE;'>#早发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59283, encryptionId=a20c59283e5, topicName=早发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c425715601, createdName=ms7258648636991762, createdTime=Wed Jun 01 06:43:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719138, encodeId=0bf31e1913808, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Thu Nov 03 22:43:27 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741679, encodeId=48fa1e4167934, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sat Aug 13 21:43:27 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845888, encodeId=6b3a18458883e, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Mon Aug 15 19:43:27 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185608, encodeId=01fa1185608d2, content=看不清, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Tue Jan 18 13:38:59 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082995, encodeId=f5a51082995e3, content=很受益,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Wed Dec 22 10:28:55 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1664142, encodeId=a6ee1664142a3, content=<a href='/topic/show?id=a20c59283e5' target=_blank style='color:#2F92EE;'>#早发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59283, encryptionId=a20c59283e5, topicName=早发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c425715601, createdName=ms7258648636991762, createdTime=Wed Jun 01 06:43:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719138, encodeId=0bf31e1913808, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Thu Nov 03 22:43:27 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741679, encodeId=48fa1e4167934, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sat Aug 13 21:43:27 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845888, encodeId=6b3a18458883e, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Mon Aug 15 19:43:27 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185608, encodeId=01fa1185608d2, content=看不清, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Tue Jan 18 13:38:59 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082995, encodeId=f5a51082995e3, content=很受益,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Wed Dec 22 10:28:55 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1664142, encodeId=a6ee1664142a3, content=<a href='/topic/show?id=a20c59283e5' target=_blank style='color:#2F92EE;'>#早发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59283, encryptionId=a20c59283e5, topicName=早发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c425715601, createdName=ms7258648636991762, createdTime=Wed Jun 01 06:43:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719138, encodeId=0bf31e1913808, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Thu Nov 03 22:43:27 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741679, encodeId=48fa1e4167934, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sat Aug 13 21:43:27 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845888, encodeId=6b3a18458883e, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Mon Aug 15 19:43:27 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185608, encodeId=01fa1185608d2, content=看不清, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Tue Jan 18 13:38:59 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082995, encodeId=f5a51082995e3, content=很受益,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Wed Dec 22 10:28:55 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1664142, encodeId=a6ee1664142a3, content=<a href='/topic/show?id=a20c59283e5' target=_blank style='color:#2F92EE;'>#早发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59283, encryptionId=a20c59283e5, topicName=早发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c425715601, createdName=ms7258648636991762, createdTime=Wed Jun 01 06:43:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719138, encodeId=0bf31e1913808, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Thu Nov 03 22:43:27 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741679, encodeId=48fa1e4167934, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sat Aug 13 21:43:27 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845888, encodeId=6b3a18458883e, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Mon Aug 15 19:43:27 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185608, encodeId=01fa1185608d2, content=看不清, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Tue Jan 18 13:38:59 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082995, encodeId=f5a51082995e3, content=很受益,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Wed Dec 22 10:28:55 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2022-01-18 杨小屁

    看不清

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1664142, encodeId=a6ee1664142a3, content=<a href='/topic/show?id=a20c59283e5' target=_blank style='color:#2F92EE;'>#早发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59283, encryptionId=a20c59283e5, topicName=早发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06c425715601, createdName=ms7258648636991762, createdTime=Wed Jun 01 06:43:27 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719138, encodeId=0bf31e1913808, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Thu Nov 03 22:43:27 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741679, encodeId=48fa1e4167934, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sat Aug 13 21:43:27 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845888, encodeId=6b3a18458883e, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Mon Aug 15 19:43:27 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185608, encodeId=01fa1185608d2, content=看不清, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210822/d15a561e055d4cdf98b4abace82dee37/464d5f63a8dd486ab01049225a87f788.jpg, createdBy=7fa65188499, createdName=杨小屁, createdTime=Tue Jan 18 13:38:59 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082995, encodeId=f5a51082995e3, content=很受益,点赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211229/06a76a2523f847ee942d4607596da751/77e2b986f5b44ff7968842b4e64e6621.jpg, createdBy=e4256406712, createdName=ms7000002136561391, createdTime=Wed Dec 22 10:28:55 CST 2021, time=2021-12-22, status=1, ipAttribution=)]
    2021-12-22 ms7000002136561391

    很受益,点赞

    0

相关资讯

2020版《CSCO胃癌诊疗指南》重磅发布,纳武利尤单抗Ⅰ级推荐列入指南

由中国临床肿瘤学会、广东省健康管理学会和中山大学附属肿瘤医院联合主办的《2020版CSCO胃癌诊疗指南》线上发布会暨首场巡讲在云端盛大召开,其中免疫治疗的更新推荐成为最大亮点。

沈琳教授:CSCO胃肠间质瘤诊疗指南发布,基于基因分型推荐治疗选择

近期,2020版《中国临床肿瘤学会(CSCO)胃肠间质瘤诊疗指南》重磅发布,这是由CSCO胃肠间质瘤专家委员编写制定的首部胃肠间质瘤指南,对于指导、规范我国GIST临床诊疗实践具有重要意义。

杨田教授:2020年版《CSCO原发性肝癌诊疗指南》更新要点解读,聚焦免疫靶向联合治疗

近两年,肝癌临床研究成果凸显,尤以内科治疗领域发展更为迅速。2020年版《CSCO原发性肝癌诊疗指南》也与时俱进,吸纳了最新的循证医学进展,更新创新治疗理念,以求更好地指导广大医生的临床实践。

看诊疗指南还需要付费 知名医生:这不利于医学发展

刚刚过去的十一假期,知名产科专家、上海春田医院管理有限公司创始人段涛遇到一件糟心事:自己参与编写和主审的诊疗指南,还要特意去第三方网站花钱付费才能查到全文。段涛是中华医学会围产医学分会的前任名誉主任委员,参与主编2012版《妊娠和产后甲状腺疾病诊疗指南》,并主审了2018版的该指南。段涛提出,中华医学会的临床指南应该是公开的、免费的,否则,将一定程度上影响循证医学发展。专家忧循证医学发展受影响段涛

免费领取指南:150份指南(50份乳腺癌、50份肺癌、50份血液肿瘤)

免费领取指南:150份指南(50份乳腺癌、50份肺癌、50份血液肿瘤),扫码即可领取更多好礼,快来了解一下!